5. Literatur

Advani, S. J.; Weichselbaum, R. R. und Roizman, B. (2000): The role of cdc2 in the expression of herpes simplex virus genes [In Process Citation], Proc Natl Acad Sci U S A 97) [20], Seite 10996-1001.

Advani, S. J.; Weichselbaum, R. R. und Roizman, B. (2001): cdc2 cyclin-dependent kinase binds and phosphorylates herpes simplex virus 1 UL 42 DNA synthesis processivity factor, J Virol 75) [21], Seite 10326-10333.

Alcami, A. und Koszinowski, U. H. (2000): Viral mechanisms of immune evasion, Trends Microbiol 8) [9], Seite 410-8..

Baldin, V.; Lukas, J.; Marcote, M. J.; Pagano, M. und Draetta, G. (1993): Cyclin D1 is a nuclear protein required for cell cycle progression in G1, Genes Dev 7) [5], Seite 812-21.

Bartek, J.; Bartkova, J. und Lukas, J. (1996): The retinoblastoma protein pathway and the restriction point, Curr Opin Cell Biol 8) [6], Seite 805-14.

Baskar, J. F.; Stanat, S. C.; Sulik, K. K. und Huang, E. S. (1983): Murine cytomegalovirus-induced congenital defects and fetal maldevelopment, J Infect Dis 148) [5], Seite 836-43.

Beisser, P. S.; Kaptein, S. J.; Beuken, E.; Bruggeman, C. A. und Vink, C. (1998): The Maastricht strain and England strain of rat cytomegalovirus represent different betaherpesvirus species rather than strains, Virology 246) [2], Seite 341-51..

Bell, S. P. und Dutta, A. (2002): DNA replication in eukaryotic cells, Annu Rev Biochem 71), Seite 333-74..

Benson, J. D. und Huang, E. S. (1990): Human cytomegalovirus induces expression of cellular topoisomerase II., J. Virol. 64) [1], Seite 9-15.

Biswas, N.; Sanchez, V. und Spector, D. H. (2003): Human cytomegalovirus infection leads to accumulation of geminin and inhibition of the licensing of cellular DNA replication, J Virol 77) [4], Seite 2369-76..

Boldogh, I.; AbuBakar, S. und Albrecht, T. (1990): Activation of proto-oncogenes: an immediate early event in human cytomegalovirus infection, Science 247), Seite 561-564.

Bresnahan, W. A.; Albrecht, T. und Thompson, E. A. (1998): The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein, J. Biol. Chem. 273) [34], Seite 22075-22082.

Bresnahan, W. A.; Boldogh, I.; Chi, P.; Thompson, E. A. und Albrecht, T. (1997): Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication, Virology 231) [2], Seite 239-47.

Bresnahan, W. A.; Boldogh, I.; Thompson, E. A. und Albrecht, T. (1996): Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1, Virology 224), Seite 150-160.

Bresnahan, W. A.; Thompson, E. A. und Albrecht, T. (1997): Human cytomegalovirus infection results in altered Cdk2 subcellular localization, J Gen Virol 78) [Pt 8], Seite 1993-7.

Brideau, R. J.; Knechtel, M. L.; Huang, A.; Vaillancourt, A.; Vera, E. E.; Oien, N. L. und Wathen, M. W. (2002): Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, againat human and animal herpesvirus, Antiviral Research 54), Seite 19-28.

Bruggeman, C. A.; Debie, W. M.; Grauls, G.; Majoor, G. und van Boven, C. P. (1983): Infection of laboratory rats with a new cytomegalo-like virus, Arch Virol 76) [3], Seite 189-99.

Bruggeman, C. A.; Meijer, H.; Dormans, P. H.; Debie, W. M.; Grauls, G. E. und van Boven, C. P. (1982): Isolation of a cytomegalovirus-like agent from wild rats, Arch Virol 73) [3-4], Seite 231-41.

Burns, W. H.; Barbour, G. M. und Sandford, G. R. (1988): Molecular cloning and mapping of rat cytomegalovirus DNA, Virology 166) [1], Seite 140-8..

Caelles, C.; Hennemann, H. und Karin, M. (1995): M-phase-specific phosphorylation of the POU transcription factor GHF-1 by a cell cycle-regulated protein kinase inhibits DNA binding, Mol Cell Biol 15) [12], Seite 6694-701.

Carnero, A. und Hannon, G. J. (1998): The INK4 family of CDK inhibitors, Curr Top Microbiol Immunol 227), Seite 43-55.

Cavanaugh, V. J.; Stenberg, R. M.; Staley, T. L.; Virgin, H. W. th; MacDonald, M. R.; Paetzold, S.; Farrell, H. E.; Rawlinson, W. D. und Campbell, A. E. (1996): Murine cytomegalovirus with a deletion of genes spanning HindIII-J and -I displays altered cell and tissue tropism, J Virol 70) [3], Seite 1365-74.

Chen, Z.; Knutson, E.; Kurosky, A. und Albrecht, T. (2001): Degradation of p21cip1 in cells productively infected with human cytomegalovirus, J. Virol. 75) [8], Seite 3613-3625.

Clurman, B. E.; Sheaff, R. J.; Thress, K.; Groudine, M. und Roberts, J. M. (1996): Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation, Genes Dev 10) [16], Seite 1979-90.

Cobbs, C. S.; Harkins, L.; Samanta, M.; Gillespie, G. Y.; Bharara, S.; King, P. H.; Nabors, L. B.; Cobbs, C. G. und Britt, W. J. (2002): Human cytomegalovirus infection and expression in human malignant glioma, Cancer Res 62) [12], Seite 3347-50..

Colberg-Poley, A. M. und Santomenna, L. D. (1988): Selective induction of chromosomal gene expression by human cytomegalovirus, Virology 166) [1], Seite 217-28.

Connolly, T.; Caligiuri, M. und Beach, D. (1997): The Cdc2 protein kinase controls Cdc10/Sct1 complex formation, Mol Biol Cell 8) [6], Seite 1105-15.

Cook, J. G.; Park, C. H.; Burke, T. W.; Leone, G.; DeGregori, J.; Engel, A.; Nevins, J. R.; Lee, D. G. und Bell, S. P. (2002): Analysis of Cdc6 function in the assembly of mammalian prereplication complexes ATPase switches controlling DNA replication initiation, Proc. Natl. Acad. Sci. U. S. A. 99) [3], Seite 1347-1352.

Costanzo, V.; Robertson, K.; Ying, C. Y.; Kim, E.; Avvedimento, E.; Gottesman, M.; Grieco, D. und Gautier, J. (2000): Reconstitution of an ATM-dependent checkpoint that inhibits chromosomal DNA replication following DNA damage, Mol Cell 6), Seite 649-659.

Coverley, D.; Laman, H. und Laskey, R. A. (2002): Distinct roles for cyclins E and A during DNA replication complex assembly and activation, Nat Cell Biol 4) [7], Seite 523-8.

Davis-Poynter, N. J.; Degli-Esposti, M. und Farrell, H. E. (1999): Murine cytomegalovirus homologues of cellular immunomodulatory genes, Intervirology 42) [5-6], Seite 331-41.

de Bruyn Kops, A. und Knipe, D. M. (1988): Formation of DNA replication structures in herpes virus-infected cells requires a viral DNA binding protein, Cell 55) [5], Seite 857-68.

DeMarchi, J. M. und Kaplan, A. S. (1976): Replication of human cytomegalovirus DNA: lack of dependence on cell DNA synthesis, J Virol 18) [3], Seite 1063-70.

Dittmer, D. und Mocarski, E. S. (1997): Human cytomegalovirus infection inhibits G1/S transition, J. Virol. 71) [2], Seite 1629-1634.

Doniger, J.; Muralidhar, S. und Rosenthal, L. J. (1999): Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate, Clin Microbiol Rev 12) [3], Seite 367-82..

Donovan, S.; Harwood, L.; Drury, L. S. und Diffley, J. F. (1997): Cdc6p-dependent loading of Mcm proteins onto pre-replicative chromatin in budding yeast.

Dulic, V.; Lees, E. und Reed, S. I. (1992): Association of human cyclin E with a periodic G1-S phase protein kinase, Science 257) [5078], Seite 1958-61.

Ehmann, G. L.; McLean, T. I. und Bachenheimer, S. L. (2000): Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells, Virology 267) [2], Seite 335-49.

El-Hodiri, H. M.; Che, S.; Nelman-Gonzalez, M.; Kuang, J. und Etkin, L. D. (1997): Mitogen-activated protein kinase and cyclin B/Cdc2 phosphorylate Xenopus nuclear factor 7 (xnf7) in extracts from mature oocytes. Implications for regulation of xnf7 subcellular localization, J Biol Chem 272) [33], Seite 20463-70.

Flemington, E. K. (2001): Herpesvirus lytic replication and the cell cycle: arresting new developments, J. Virol. 75) [10], Seite 4475-4481.

Fortunato, E. A.; Sanchez, V.; Yen, J. Y. und Spector, D. H. (2002): Infection of cells with human cytomegalovirus during S phase results in a blockade to immediate-early gene expression that can be overcome by inhibition of the proteasome, J Virol 76) [11], Seite 5369-79..

Fortunato, E. A.; Sommer, M. H.; Yoder, K. und Spector, D. H. (1997): Identification of domains within the human cytomegalovirus major immediate-early 86-kilodalton protein and the retinoblastoma protein required for physical and functional interaction with each other, J. Virol. 71) [11], Seite 8176-8185.

Fujita, M.; Yamada, C.; Tsurumi, T.; Hanaoka, F.; Matsuzawa, K. und Inagaki, M. (1998): Cell cycle- and chromatin binding state-dependent phosphorylation of human MCM heterohexameric complexes. A role for cdc2 kinase, J Biol Chem 273) [27], Seite 17095-101.

Geng, Y.; Eaton, E. N.; Picon, M.; Roberts, J. M.; Lundberg, A. S.; Gifford, A.; Sardet, C. und Weinberg, R. A. (1996): Regulation of cyclin E transcription by E2Fs and retinoblastoma protein, Oncogene 12) [6], Seite 1173-80.

Gerna, G.; Zipeto, D.; Percivalle, E.; Parea, M.; Revello, M. G.; Maccario, R.; Peri, G. und Milanesi, G. (1992): Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients, J Infect Dis 166) [6], Seite 1236-44.

Gonzalez Armas, J. C.; Morello, C. S.; Cranmer, L. D. und Spector, D. H. (1996): DNA immunization confers protection against murine cytomegalovirus infection, J Virol 70) [11], Seite 7921-8.

Griffith, B. P.; Chen, M. und Isom, H. C. (1990): Role of primary and secondary maternal viremia in transplacental guinea pig cytomegalovirus transfer, J Virol 64) [5], Seite 1991-7.

Hagemeier, C.; Caswell, R.; Hayhurst, G.; Sinclair, J. und Kouzarides, T. (1994): Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein, EMBO J. 13) [12], Seite 2897-2903.

Harbour, J. W. und Dean, D. C. (2000): Rb function in cell-cycle regulation and apoptosis, Nat Cell Biol 2) [4], Seite E65-7.

Harkins, L.; Volk, A. L.; Samanta, M.; Mikolaenko, I.; Britt, W. J.; Bland, K. I. und Cobbs, C. S. (2002): Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer, Lancet 360) [9345], Seite 1557-63..

Hartwell, L. H. und Weinert, T. A. (1989): Checkpoints: controls that ensure the order of cell cycle events, Science 246) [4930], Seite 629-34.

Hayashi, M. Lu; Blankenship, C. und Shenk, T. (2000): Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle, Proc. Natl. Acad. Sci. USA 97) [6], Seite 2692-2696.

He, W.; Staples, D.; Smith, C. und Fisher, C. (2003): Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7, J Virol 77) [19], Seite 10566-10574.

Hendzel, M. J.; Wei, Yi; Mancini, M. A.; Van Hooser, A.; Ranalli, T.; Brinkley, B. R.; Bazett-Jones, D. P. und Allis, C. D. (1997): Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation, Chromosoma 106), Seite 348-360.

Hengst, L. und Reed, S. I. (1998): Inhibitors of the Cip/Kip family, Curr Top Microbiol Immunol 227), Seite 25-41.

Horvat, R. T.; Parmely, M. J. und Chandran, B. (1993): Human Herpesvirus 6 inhibits the proliferative responses of human peripheral blood mononuclear cells, J Infect Dis 167), Seite 1274-1280.

Isom, H. C. (1979): Stimulation of ornithine decarboxylase by human cytomegalovirus, J Gen Virol 42) [2], Seite 265-78.

Jackman, M. R. und Pines, J. N. (1997): Cyclins and the G2/M transition, Cancer Surv 29), Seite 47-73.

Jault, F. M.; Jault, J.-M.; Ruchti, F.; Fortunato, E. A.; Clark, C.; Corbeil, J.; Richman, D. D. und Spector, D. H. (1995): Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest, J. Virol. 69) [11], Seite 6697-6704.

Kalejta, R. F.; Bechtel, J. T. und Shenk, T. (2003): Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors, Mol Cell Biol 23) [6], Seite 1885-95..

Kalejta, R. F. und Shenk, T. (2002): Manipulation of the cell cycle by human cytomegalovirus, Front. Biosci. 7), Seite D295-306..

Kalejta, R. F. und Shenk, T. (2003): The human cytomegalovirus UL82 gene product (pp71) accelerates progression through the G1 phase of the cell cycle, J Virol 77) [6], Seite 3451-9.

Kalejta, R. F. und Shenk, T. (2003): Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein, Proc Natl Acad Sci U S A 100) [6], Seite 3263-8..

Kishimoto, T. und Okumura, E. (1997): In vivo regulation of the entry into M-phase: initial activation and nuclear translocation of cyclin B/Cdc2, Prog Cell Cycle Res 3), Seite 241-9.

Kondo, K.; Kaneshima, H. und Mocarski, E. S. (1994): Human cytomegalovirus latent infection of granulocyte-macrophage progenitors, Proc Natl Acad Sci U S A 91) [25], Seite 11879-83.

Labib, K.; Tercero, J. A. und Diffley, J. F. (2000): Uninterrupted MCM2-7 function required for DNA replication fork progression, Science 288) [5471], Seite 1643-7.

Laemmli, U. K. (1970): Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227) [259], Seite 680-5.

Lagenaur, L. A.; Manning, W. C.; Vieira, J.; Martens, C. L. und Mocarski, E. S. (1994): Structure and function of the murine cytomegalovirus sgg1 gene: a determinant of viral growth in salivary gland acinar cells, J Virol 68) [12], Seite 7717-27.

Lazaro, J. B.; Bailey, P. J. und Lassar, A. B. (2002): Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation, Genes Dev 16), Seite 1792-1805.

Lembo, D.; Gribaudo, G.; Cavallo, R.; Riera, L.; Angeretti, A.; Hertel, L. und Landolfo, S. (1999): Human cytomegalovirus stimulates cellular dihydrofolate reductase activity in quiescent cells, Intervirology 42) [1], Seite 30-6.

Leone, G.; DeGregori, J.; Yan, Z.; Jakoi, L.; Ishida, S.; Williams, R. S. und Nevins, J. R. (1998): E2F3 activity is regulated during the cell cycle and is required for the induction of S phase, Genes Dev 12) [14], Seite 2120-30..

Lew, D. J. und Kombluth, S. (1996): Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control, Curr Opin Cell Biol 8), Seite 795-804.

Li, J.; Meyer, A. N. und Donoghue, D. J. (1997): Nuclear localization of Cyclin B1 mediates its biological activity and is regulated by phosphorylation, Proc Natl Acad Sci U S A 94), Seite 502-507.

Li, R. Y. und Tsutsui, Y. (2000): Growth retardation and microcephaly induced in mice by placental infection with murine cytomegalovirus, Teratology 62) [2], Seite 79-85.

Liang, C.; Weinreich, M. und Stillman, B. (1995): ORC and Cdc6p interact and determine the frequency of initiation of DNA replication in the genome, Cell 81) [5], Seite 667-76.

Ljungman, P. (2002): Betaherpesvirus Challenges in the Transplant Recipient, The Journal of Infectious Diseases 186), Seite S99-109.

Lomonte, P. und Everett, R. (1999): Herpes simplex virus type 1 immediate-early protein Vmw110 inhibits progression of cells through mitosis and from G1 into S phase of the cell cycle, J Virol 73), Seite 9456-9467.

Lu, M. und Shenk, T. (1996): Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S, J. Virol. 70) [12], Seite 8850-8857.

Lu, M. und Shenk, T. (1999): Human cytomegalovirus UL69 protein induces cells to accumulate in G1 phase of the cell cycle, J. Virol. 73) [1], Seite 676-683.

Lukas, C.; Sorensen, C. S.; Kramer, E.; Santoni-Rugiu, E.; Lindeneg, C.; Peters, J. M.; Bartek, J. und Lukas, J. (1999): Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex, Nature 401) [6755], Seite 815-8.

MacDonald, M. R.; Li, X. Y.; Stenberg, R. M.; Campbell, A. E. und Virgin, H. W. th (1998): Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant, J Virol 72) [1], Seite 442-51.

Mailand, N.; Podtelejnikov, A.V.; Groth, A.; Mann, M.; Bartek, J. und Lukas, J. (2002): Ragulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability, Embo J 21) [21], Seite 5911-20.

Masai, H. und Arai, K-I (2002): Cdc7 kinase complex: a key regulator in the initiation of DNA replication, J Cell Physiol 190), Seite 287-296.

Masai, H.; Matsui, E.; You, Z.; Ishimi, Y.; Tamai, K. und Arai, K. (2000): Human Cdc7-related kinase complex. In vitro phosphorylation of MCM by concerted actions of Cdks and Cdc7 and that of a criticial threonine residue of Cdc7 bY Cdks, J. Biol. Chem. 275) [37], Seite 29042-29052.

McElroy, A. K.; Dwarakanath, R. S. und Spector, D. H. (2000): Dysregulation of cyclin E gene expression in human cytomegalovirus-infected cells requires viral early gene expression and is associated with changes in the Rb-related protein p130, J Virol 74) [9], Seite 4192-206.

Meijer, H.; Dreesen, J. C. und Van Boven, C. P. (1986): Molecular cloning and restriction endonuclease mapping of the rat cytomegalovirus genome, J Gen Virol 67 ( Pt 7)), Seite 1327-42.

Meijer, L. (1996): Chemical inhibitors of cyclin-dependent kinases., Trends Cell Biol. 6), Seite 393-397.

Melnick, J. L.; Adam, E. und DeBakey, M. E. (1995): Cytomegalovirus and atherosclerosis, Bioessays 17) [10], Seite 899-903.

Mendez, J. und Stillman, B. (2000): Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis, Mol Cell Biol 20) [22], Seite 8602-12..

Michelson, S. (1999): Human cytomegalovirus escape from immune detection, Intervirology 42) [5-6], Seite 301-7.

Mocarski, E. S. (2001): Cytomegaloviruses and their replication, Knipe, D. M.; Howley, P. M. und al., et, Fields Virology, Seite 2448-2492, Lippincott Williams & Wilkins, Philadelphia, Pa..

Morello, C. S.; Ye, M. und Spector, D. H. (2002): Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication, J Virol 76) [10], Seite 4822-35.

Morris, M. C.; Gondeau, C.; Tainer, J. A. und Divita, G. (2002): Kinetic mechanism of activation of the Cdk2/cyclin A complex. Key role of the C-lobe of the Cdk, J Biol Chem 277) [26], Seite 23847-53.

Muralidhar, S.; Doniger, J.; Mendelson, E.; Araujo, J. C.; Kashanchi, F.; Azumi, N.; Brady, J. N. und Rosenthal, L. J. (1996): Human cytomegalovirus mtrII oncoprotein binds to p53 and down-regulates p53-activated transcription, J Virol 70) [12], Seite 8691-700.

Muranyi, W.; Haas, J.; Wagner, M.; Krohne, G. und Koszinowski, U. H. (2002): Cytomegalovirus recruitment of cellular kinases to dissolve the nuclear lamina, Science 297), Seite 854-857.

Nyberg, K.; Michelson, R. J.; Putnam, C. W. und Weinert, T. A. (2002): Toward maintaining the genom: DNA damage and replication checkpoints, Annu. Rev. Genet. 36), Seite 617-56.

Oegema, K.; Desai, A.; Rybina, S.; Kirkham, M. und Hyman, A. A. (2001): Functional analysis of kinetochore assembly in Caenorhabditis elegans, J Cell Biol 153) [6], Seite 1209-26.

Ohtani, K.; DeGregori, J.; Leone, G.; Herendeen, D. R.; Kelly, T. J. und Nevins, J. R. (1996): Expression of the HsOrc1 gene, a human ORC1 homolog, is regulated by cell proliferation via the E2F transcription factor, Mol Cell Biol 16) [12], Seite 6977-84..

Ohtani, K.; DeGregori, J. und Nevins, J. R. (1995): Regulation of the cyclin E gene by transcription factor E2F1, Proc Natl Acad Sci U S A 92) [26], Seite 12146-50.

Pass, R. F. (1985): Epidemiology and transmission of cytomegalovirus, J Infect Dis 152) [2], Seite 243-8..

Pass, R. F. (2001): Cytomegalovirus, Knipe, D. M. und Howley, P. M., Fields Virology, Lippincott Williams & Wilkins, Philadelphia, PA.

Piatti, S.; Bohm, T.; Cocker, J. H.; Diffley, J. F. und Nasmyth, K. (1996): Activation of S-phase-promoting CDKs in late G1 defines a "point of no return" after which Cdc6 synthesis cannot promote DNA replication in yeast, Genes Dev 10) [12], Seite 1516-31.

Piatti, S.; Lengauer, C. und Nasmyth, K. (1995): Cdc6 is an unstable protein whose de novo synthesis in G1 is important for the onset of S phase and for preventing a 'reductional' anaphase in the budding yeast Saccharomyces cerevisiae, Embo J 14) [15], Seite 3788-99.

Pines, J. und Hunter, T. (1989): Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2, Cell 58) [5], Seite 833-46.

Pines, J. und Hunter, T. (1990): Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B, Nature 346) [6286], Seite 760-3.

Plachter, B.; Sinzger, C. und Jahn, G. (1996): Cell types involved in replication and distribution of human cytomegalovirus, Adv Virus Res 46), Seite 195-261.

Planas-Silva, M. D. und Weinberg, R. A. (1997): The restriction point and control of cell proliferation, Curr Opin Cell Biol 9) [6], Seite 768-72.

Poma, E. E.; Kowalik, T. F.; Zhu, L.; Sinclair, J. H. und Huang, E.-S. (1996): The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter, J. Virol. 70) [11], Seite 7867-7877.

Priscott, P. K. und Tyrrell, D. A. (1982): The isolation and partial characterisation of a cytomegalovirus from the brown rat, Rattus norvegicus, Arch Virol 73) [2], Seite 145-60.

Prösch, S.; Wendt, C. E.; Reinke, P.; Priemer, C.; Oppert, M.; Kruger, D. H.; Volk, H. D. und Docke, W. D. (2000): A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation, Virology 272) [2], Seite 357-65.

Quelle, D. E.; Ashmun, R. A.; Shurtleff, S. A.; Kato, J. Y.; Bar-Sagi, D.; Roussel, M. F. und Sherr, C. J. (1993): Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts, Genes Dev 7) [8], Seite 1559-71.

Rawlinson, W. D.; Farrell, H. E. und Barrell, B. G. (1996): Analysis of the complete DNA sequence of murine cytomegalovirus, J Virol 70) [12], Seite 8833-49.

Razzaque, A.; Zhu, F. und Jones, C. (1991): Functional analysis of human cytomegalovirus morphological transforming region II (mtrII), Virology 181) [1], Seite 399-402.

Reddehase, M. J.; Dreher-Stumpp, L.; Angele, P.; Balthesen, M. und Susa, M. (1992): Hematopoietic stem cell deficiency resulting from cytomegalovirus infection of bone marrow stroma, Ann Hematol 64 Suppl), Seite A125-7.

Reddehase, M. J.; Podlech, J. und Grzimek, N. K. (2002): Mouse models of cytomegalovirus latency: overview, J Clin Virol 25 Suppl 2), Seite S23-36.

Roizman, B. und Jr., P. R. R. (1964): Multiplication of herpes simplex virus. II. The relation between protein synthesis and the duplication of viral DNA in infected HEp-2 cells., Virology 22), Seite 262-269.

Roizman, B. und Knipe, D. M. (2001): Herpes simplex viruses and their replication, Knipe, D. M. und Howley, P. M., Fields Virology, 4.. Auflage, Seite 2399-2459, Lippincott Williams & Wilkins, Philadelphia, Pa..

Roizman, B. und Pellett, P. E. (2001): The Family Herpesviridae: A Brief Introduction, Knipe, D. M. und Howley, P. M., Fields Virology, Lippincott Williams & Wilkins, Philadelphia, Pa..

Saederup, N.; Lin, Y. C.; Dairaghi, D. J.; Schall, T. J. und Mocarski, E. S. (1999): Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host, Proc Natl Acad Sci U S A 96) [19], Seite 10881-6.

Salvant, B. S.; Fortunato, E. A. und Spector, D. H. (1998): Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription, J. Virol. 72), Seite 3729-3741.

Sanchez, V.; McElroy, A. K. und Spector, D. H. (2003): Mechanisms govering maintenance of Cdk1/ Cyclin B1 kinase activity in cells infected with human Cytomegalovirus, J Virol 77) [24], Seite 13214-13224.

Shadan, F. F.; Cowsert, L. M. und Villarreal, L. P. (1994): n-Butyrate, a cell cycle blocker, inhibits the replication of polyomaviruses and papillomaviruses but not that of adenoviruses and herpesviruses, J Virol 68) [8], Seite 4785-96.

Shanley, J. D.; Morningstar, J. und Jordan, M. C. (1985): Inhibition of murine cytomegalovirus lung infection and interstitial pneumonitis by acyclovir and 9-(1,3-dihydroxy-2-propoxymethyl)guanine, Antimicrob Agents Chemother 28) [2], Seite 172-5.

Sherr, C. J. (1995): D-type cyclins, Trends Biochem Sci 20) [5], Seite 187-90.

Sinclair, J.; Baillie, J.; Bryant, L. und Caswell, R. (2000): Human cytomegalovirus mediates cell cycle progression through G(1) into early S phase in terminally differentiated cells, J Gen Virol 81) [Pt 6], Seite 1553-1565.

Singer, J. D.; Gurian-West, M.; Clurman, B. und Roberts, J. M. (1999): Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells, Genes Dev 13) [18], Seite 2375-87.

Sinzger, C. und Jahn, G. (1996): Human cytomegalovirus cell tropism and pathogenesis, Intervirology 39) [5-6], Seite 302-19..

Smith, M. G. (1954): Propagation of salivary gland virus of the mouse in tissue cultures., Proc. Soc. Exp. Biol. Med. 86:435-440).

Smits, V. A. J. und Medema, R. H. (2001): Checking out the G2/M transition, Biochimica et Biophysica Acta 1519), Seite 1-12.

Soderberg-Naucler, C.; Fish, K. N. und Nelson, J. A. (1997): Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors, Cell 91) [1], Seite 119-26.

Song, B.; Liu, J. J.; Yeh, K. C. und Knipe, D. M. (2000): Herpes simplex virus infection blocks events in the G1 phase of the cell cycle, Virology 267) [2], Seite 326-34.

Song, Y. J. und Stinski, M. F. (2002): Effect of the human cytomegalovirus IE86 protein on expression of E2F-responsive genes: A DNA microarray analysis, Proc. Natl. Acad. Sci. U. S. A. 99) [5], Seite 2836-2841.

Span, A. H.; Grauls, G.; Bosman, F.; van Boven, C. P. und Bruggeman, C. A. (1992): Cytomegalovirus infection induces vascular injury in the rat, Atherosclerosis 93) [1-2], Seite 41-52.

Speir, E.; Modali, R.; Huang, E. S.; Leon, M. B.; Shawl, F.; Finkel, T. und Epstein, S. E. (1994): Potential role of human cytomegalovirus and p53 interaction in coronary restenosis, Science 265) [5170], Seite 391-4..

Stagno, S.; Pass, R. F.; Cloud, G.; Britt, W. J.; Henderson, R. E.; Walton, P. D.; Veren, D. A.; Page, F. und Alford, C. A. (1986): Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome, Jama 256) [14], Seite 1904-8..

Stals, F. S.; Zeytinoglu, A.; Havenith, M.; de Clercq, E. und Bruggeman, C. A. (1993): Rat cytomegalovirus-induced pneumonitis after allogeneic bone marrow transplantation: effective treatment with (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine, Antimicrob Agents Chemother 37) [2], Seite 218-23.

Swanton, C.; Mann, D. J.; Fleckenstein, B.; Neipel, F.; Peters, G. und Jones, N. (1997): Herpes viral cyclin/Cdk6 complexes evade inhibition of CDK inhibitor proteins, Nature 390), Seite 184-7.

Sweet, C. (1999): The pathogenicity of cytomegalovirus, FEMS Microbiol Rev 23) [4], Seite 457-82.

Taylor-Wiedeman, J.; Sissons, J. G.; Borysiewicz, L. K. und Sinclair, J. H. (1991): Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells, J Gen Virol 72), Seite 2059-64.

Thompson, J.; Doniger, J. und Rosenthal, L. J. (1994): A 79 amino acid oncogene is responsible for human cytomegalovirus mtrII induced malignant transformation, Arch Virol 136) [1-2], Seite 161-72.

Todorvo, I. T.; Attaran, A. und Kearsey, S. E. (1995): BM28, a human member of the MCM2-3-5 family, is displaced from chromatin during DNA replication., J Cell Biol 129), Seite 1433-1445.

Toorkey, C. B. und Carrigan, D. R. (1989): Immunohistochemical detection of an immediate early antigen of human cytomegalovirus in normal tissues, J Infect Dis 160) [5], Seite 741-51.

Tsutsui, Y. (1995): Developmental disorders of the mouse brain induced by murine cytomegalovirus: animal models for congenital cytomegalovirus infection, Pathol Int 45) [2], Seite 91-102.

Turtinen, L. W.; Saltzman, R.; Jordan, M. C. und Haase, A. T. (1987): Interactions of human cytomegalovirus with leukocytes in vivo: analysis by in situ hybridization, Microb Pathog 3) [4], Seite 287-97.

van Den Pol, A. N.; Mocarski, E.; Saederup, N.; Vieira, J. und Meier, T. J. (1999): Cytomegalovirus cell tropism, replication, and gene transfer in brain, J Neurosci 19) [24], Seite 10948-65.

Vieira, J.; Farrell, H. E.; Rawlinson, W. D. und Mocarski, E. S. (1994): Genes in the HindIII J fragment of the murine cytomegalovirus genome are dispensable for growth in cultured cells: insertion mutagenesis with a lacZ/gpt cassette, J Virol 68) [8], Seite 4837-46.

Vink, C.; Beuken, E. und Bruggeman, C. A. (2000): Complete DNA sequence of the rat cytomegalovirus genome, J Virol 74) [16], Seite 7656-65.

Vousden, K. H. (1995): Regulation of the cell cycle by viral oncoproteins, Semin Cancer Biol 6) [2], Seite 109-16.

Wade, M.; Kowalik, T. F.; Mudryj, M.; Huang, E. S. und Azizkhan, J. C. (1992): E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection, Mol Cell Biol 12) [10], Seite 4364-74.

Waterborg, J. H. und Matthews, H. R. (1994): The Lowry method for protein quantitation, Methods Mol Biol 32), Seite 1-4.

Weinreich, M. und Stillman, B. (1999): Cdc7p-Dbf4p kinase binds to chromatin during S phase and is regulated by both the APC and RAD53 checkpoint pathway, Embo J 18), Seite 5334-5346.

Wentworth, B. B. und French, L. (1970): Plaque assay of CMV strains of human origin, P.S.E.B.M..

Wiebusch, L.; Asmar, J.; Uecker, R. und Hagemeier, C. (2003): Human cytomegalovirus immediate-early over protein 2 (IE2)-mediated activation of cyclin E is cell-cycle-independent and forces S-phase entry in IE2-arrested cells, J Gen Virol 84) [Pt 1], Seite 51-60..

Wiebusch, L. und Hagemeier, C. (2001): The human cytomegalovirus immediate early 2 protein dissociates cellular DNA synthesis from cyclin-dependent kinase activation, EMBO J. 20) [5], Seite 1086-1098..

Wiebusch, L.; Uecker, R. und Hagemeier, C. (2003): Human cytomegalovirus prevents replication licensing by inhibiting MCM loading onto chromatin, EMBO Rep 4) [1], Seite 42-6..

Won, K. A. und Reed, S. I. (1996): Site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E, EMBO J. 15), Seite 4182-4193.

Yam, CH.; Fung, TK. und Poon, RY. (2002): Cyclin A in cell cycle control and cancer, Cell Mol Life Sci. 59) [8], Seite 1317-26.

Ye, M.; Duus, K. M.; Peng, J.; Price, D. H. und Grose, C. (1999): Varicella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase, J Virol 73) [2], Seite 1320-30.

Zafiropoulos, A.; Tsentelierou, E.; Billiri, K. und Spandidos, D. A. (2003): Human herpes viruses in non-melanoma skin cancers, Cancer Lett 198) [1], Seite 77-81.

Zhang, H. S.; Gavin, M.; Dahiya, A.; Postigo, A. A.; Ma, D.; Luo, R. X.; Harbour, J. W. und Dean, D. C. (2000): Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF, Cell 101) [1], Seite 79-89.

Zhang, Z.; Huong, S. M.; Wang, X.; Huang, D. Y. und Huang, E. S. (2003): Interaction between human cytomegalovirus IE1-72 and cellular p107: Functional Domains and Mechanisms of up-regulation of cyclin E/ cdk2 kinase activity, J Virol 77) [23], Seite 12660-12670.

Zhu, H.; Cong, J. P.; Mamtora, G.; Gingeras, T. und Shenk, T. (1998): Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays, Proc Natl Acad Sci U S A 95) [24], Seite 14470-5.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
XDiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
13.11.2006